Viral vectors made in human expression system allow for safer and more efficient production of novel vaccines and gene therapy

12.2013 - SIRION Biotech announced today it is now providing viral vectors for preclinical use to be expressed in CEVEC's CAP®-Technology. CAP® cell lines are designed for stable and transient protein production and achieve highest protein yields with authentic human glycosylation patterns. ...